Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

CAPRICOR THERAPEUTICS, INC.

CAPR · Nasdaq · CIK 0001133869 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

18 Form 4 transaction lines observed in the same window
8 sales · 10 option, withholding, award, gift or other lines

Last qualifying purchase2024-09-20 · Nippon Shinyaku Co Ltd · $15.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Bergmann AnthonyCHIEF FINANCIAL OFFICER
○▼○○▼○▼○▼
Krasney KarenEVP, GENERAL COUNSEL
○▼○▼○▼○▼
Litvack FrankDirector
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-09-20 · Nippon Shinyaku Co Ltd.

Recent Form 4 activity

0Purchases
10Sales
14Other Form 4 lines
12SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING8 sale line(s) · context only
OTHER10 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
18,825,352
Previous report
19,680,648
Avg daily volume
4,165,921
Days to cover
4.5

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2024-09-20Nippon Shinyaku Co LtdPurchase (P)Common Stock, par value $0.001 per share2,798,507USD 5.36USD 14,999,998SEC filing ↗
2023-10-12Musket David BPurchase (P)Common Stock410USD 2.75USD 1,128SEC filing ↗
2023-10-10COLLIER EARL M JRPurchase (P)Common Stock10,000USD 2.83USD 28,300SEC filing ↗
2023-10-09Musket David BPurchase (P)Common Stock5,083USD 2.82USD 14,334SEC filing ↗
2023-10-06Auwaerter Paul GisbertPurchase (P)Common Stock5,000USD 2.84USD 14,200SEC filing ↗
2023-10-04Musket David BPurchase (P)Common Stock2,500USD 2.90USD 7,250SEC filing ↗
2022-07-06Avat XavierPurchase (P)Common Stock1,000USD 3.68USD 3,680SEC filing ↗
2022-06-29Avat XavierPurchase (P)Common Stock1,500USD 3.76USD 5,640SEC filing ↗

Form 4 evidence

24 transaction lines in the latest 365-day window; 75 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-25Krasney KarenSale (S)Common Stock24,100USD 30.38USD 732,158SEC filing ↗
2026-06-25Krasney KarenOption exercise / conversion (M)Common Stock24,100USD 3.18USD 76,638SEC filing ↗
2026-06-25Bergmann AnthonySale (S)Common Stock24,100USD 30.38USD 732,158SEC filing ↗
Show recent Form 4 evidence (24 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-25Krasney KarenSale (S)Common Stock24,100USD 30.38USD 732,158SEC filing ↗
2026-06-25Krasney KarenOption exercise / conversion (M)Common Stock24,100USD 3.18USD 76,638SEC filing ↗
2026-06-25Bergmann AnthonySale (S)Common Stock24,100USD 30.38USD 732,158SEC filing ↗
2026-06-25Bergmann AnthonyOption exercise / conversion (M)Common Stock24,100USD 3.18USD 76,638SEC filing ↗
2026-06-24Krasney KarenSale (S)Common Stock400USD 30.00USD 12,000SEC filing ↗
2026-06-24Krasney KarenOption exercise / conversion (M)Common Stock400USD 3.18USD 1,272SEC filing ↗
2026-06-24Bergmann AnthonySale (S)Common Stock400USD 30.00USD 12,000SEC filing ↗
2026-06-24Bergmann AnthonyOption exercise / conversion (M)Common Stock400USD 3.18USD 1,272SEC filing ↗
2026-06-22Krasney KarenSale (S)Common Stock500USD 30.00USD 15,000SEC filing ↗
2026-06-22Krasney KarenOption exercise / conversion (M)Common Stock500USD 3.18USD 1,590SEC filing ↗
2026-06-22Bergmann AnthonySale (S)Common Stock500USD 30.00USD 15,000SEC filing ↗
2026-06-22Bergmann AnthonyOption exercise / conversion (M)Common Stock500USD 3.18USD 1,590SEC filing ↗
2026-05-18Bergmann AnthonyOption exercise / conversion (M)Common Stock3,000USD 1.39USD 4,170SEC filing ↗
2026-05-13Litvack FrankOption exercise / conversion (M)Common Stock3,937USD 1.39USD 5,472SEC filing ↗
2026-05-01Krasney KarenSale (S)Common Stock25,000USD 31.70USD 792,500SEC filing ↗
2026-05-01Krasney KarenOption exercise / conversion (M)Common Stock25,000USD 3.18USD 79,500SEC filing ↗
2026-05-01Bergmann AnthonySale (S)Common Stock25,000USD 31.70USD 792,500SEC filing ↗
2026-05-01Bergmann AnthonyOption exercise / conversion (M)Common Stock25,000USD 3.18USD 79,500SEC filing ↗
2026-04-02Sabar Karimah EsSale (S)Common Stock7,529USD 32.00USD 240,928SEC filing ↗
2026-04-02Sabar Karimah EsOption exercise / conversion (M)Common Stock7,529USD 3.18USD 23,942SEC filing ↗
2026-04-01Sabar Karimah EsSale (S)Common Stock53,735USD 31.03USD 1,667,397SEC filing ↗
2026-04-01Sabar Karimah EsOption exercise / conversion (M)Common Stock53,735USD 4.86USD 261,152SEC filing ↗
2025-12-30Krasney KarenOption exercise / conversion (M)Common Stock2,500USD 1.39USD 3,475SEC filing ↗
2025-12-19DUNBAR GEORGE W JROption exercise / conversion (M)Common Stock3,000USD 1.39USD 4,170SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCAPR
CIK0001133869
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history75 transaction lines from 2020-07-27 to 2026-06-25
8 P purchase lines · 14 S sale lines · 53 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.